Yes. And talk of a CYDY buyout is not a bunch of baseless pumping or idle speculation. It is a very real possibility. I would go as far as to say it is a likelihood. Not just because CYDY is a tiny company with a potential blockbuster product. But because if PRO140 is approved CytoDyn will have literally no other choice but to be acquired or partner. Acquisition makes the most sense in my mind as CYDY does not bring anything substantial to the table besides PRO140. They have no infrastructure of any kind. No intangible assets. No partnerships to speak of. No sales and distribution experience or connections to my knowledge. A company looking to purchase PRO-140 could acquire CYDY without paying a premium for the above mentioned assets, which they most certainly would already own. Without question that would be an attractive transaction.